Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.907
+0.007 (0.72%)
At close: Nov 22, 2024, 4:00 PM
0.910
+0.003 (0.29%)
After-hours: Nov 22, 2024, 7:45 PM EST
Ocugen Market Cap
Ocugen has a market cap or net worth of $264.34 million as of November 22, 2024. Its market cap has increased by 172.52% in one year.
Market Cap
264.34M
Enterprise Value
232.43M
1-Year Change
172.52%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since December 3, 2014, Ocugen's market cap has increased from $126.80M to $264.34M, an increase of 108.47%. That is a compound annual growth rate of 7.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 254.60M | 72.61% |
| Dec 29, 2023 | 147.50M | -48.17% |
| Dec 30, 2022 | 284.60M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.67% |
| Dec 31, 2020 | 296.50M | 3,472.29% |
| Dec 31, 2019 | 8.30M | 50.91% |
| Dec 31, 2018 | 5.50M | -88.84% |
| Dec 29, 2017 | 49.30M | 85.34% |
| Dec 30, 2016 | 26.60M | -42.80% |
| Dec 31, 2015 | 46.50M | -60.86% |
| Dec 31, 2014 | 118.80M | -6.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rezolute | 271.81M |
| NeuroPace | 268.63M |
| Precigen | 264.43M |
| Artiva Biotherapeutics | 264.15M |
| Poseida Therapeutics | 264.13M |
| Zynex | 258.27M |
| Lifecore Biomedical | 257.05M |
| Lyell Immunopharma | 255.93M |